Skip to main content
. 2021 May 7;15:927–937. doi: 10.2147/PPA.S306132

Table 1.

Patient Demographics

Total (n=16) Online Survey (n=93)
Age, mean (range) 61 (48–82) 44 (23–70)
Age at diagnose, mean (range) 42 (29–70) 35 (15–64)
Gender, n (%)a
Male 3 (19) 22 (24)
Female 13 (81) 70 (75)
MS Typeb
RRMS 9 (56) 72 (77)
PPMS 2 (13) 11 (12)
SPMS 4 (25) 9 (10)
Disease severity, n (%)c
Mild 1 (6) 19 (20)
Moderate 8 (50) 20 (22)
Severe 4 (25) 4 (4)
Unknown 3 (19) 33 (18)
Treatment, n (%)
Treatment naïve 4 (25) 10 (11)
Treatment experienced, but not currently on DMTd 9 (56) 20 (22)
On 1st line DMT 2 (13) 17 (18)
On 2nd line DMT 1 (6) 46 (50)
Marital status, n (%)
Single 19 (20)
Partnered 1 (6) 23 (25)
Married 12 (75) 44 (47)
Divorced 1 (6) 5 (5)
Widowed 2 (13) 2 (2)
Education, n (%)
Primary/secondary education 7 (44) 10 (11)
Vocational/technical education 7 (44) 44 (47)
University 2 (13) 39 (42)

Notes: aThe online survey also provided the answer category: prefer not to say (n=1), bThe online survey also provided the answer category: clinically isolated syndrome (n=1), cThe online survey had n=17 (18%) missing, dIn the focus groups the number of past disease-modifying therapies (DMT) used ranged from 1–4.

Abbreviations: MS, multiple sclerosis; PPMS, primary progressive multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; SPMS, secondary progressive multiple sclerosis.